Traws Pharma, Inc. Stock Issued During Period, Value, Restricted Stock Award, Gross
Traws Pharma, Inc. (TRAW) reported Stock Issued During Period, Value, Restricted Stock Award, Gross of $3.16 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross · last filed 2026-08-14
- 2025-06-30: Stock Issued During Period, Value, Restricted Stock Award, Gross 6 month $3.16M.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 6 month |
|---|---|
| 2025-06-30 | $3.16M 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |